8-methoxypsoralen and ultraviolet a radiation activate the human elastin promoter in transgenic mice: in vivo and in vitro evidence for gene induction.
Treatment of skin diseases with the combination of 8-methoxypsoralen and ultraviolet A radiation (PUVA) results in clinical alterations in treated skin that resemble those observed in chronically photodamaged skin. The PUVA-treated patients develop nonmelanoma skin cancers, pigmentary alterations and wrinkling characteristic of sun-induced changes. The major alteration in the dermis of sun-damaged skin is the deposition of abnormal elastic fibers, termed solar elastosis. Up-regulation of elastin promoter activity in dermal fibroblasts explains the excess elastic tissue but not the reason for the aberrant morphology of the elastotic material. In order to study photoaging in an experimental system, we utilized a transgenic mouse line that expresses the human elastin promoter/chloramphenicol acetyltransferase construct in a tissue-specific and developmentally regulated manner. Although UVB radiation has been demonstrated to increase promoter activity in vitro, UVA fails to demonstrate a similar effect at the doses utilized. In this study, we demonstrate the ability of PUVA treatment to up-regulate elastin promoter activity both in vitro and in vivo. These data help to explain the development of photoaging in sun-protected PUVA-treated skin. We attribute the up-regulation of elastin promoter activity in response to PUVA to the formation of DNA photoadducts, which do not occur in response to UVA radiation alone.
Bernstein
E F
EF
Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Gasparro
F P
FP
Brown
D B
DB
Takeuchi
T
T
Kong
S K
SK
Uitto
J
J
D000818:Animals; D002478:Cells, Cultured; D004549:Elastin / Q000096:biosynthesis / Q000235:genetics*; D005347:Fibroblasts / Q000187:drug effects / Q000528:radiation effects; D005786:Gene Expression Regulation / Q000187:drug effects* / Q000528:radiation effects*; D006801:Humans; D008730:Methoxsalen / Q000494:pharmacology; D051379:Mice; D008822:Mice, Transgenic; D011701:PUVA Therapy; D017319:Photosensitizing Agents / Q000494:pharmacology; D011401:Promoter Regions, Genetic / Q000187:drug effects* / Q000528:radiation effects*; D015533:Transcriptional Activation; D014466:Ultraviolet Rays
D017319:Photosensitizing Agents; D004549:Elastin; D008730:Methoxsalen